STATE STREET CORP - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 118 filers reported holding SUTRO BIOPHARMA INC in Q1 2024. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2024$4,586,350
-32.2%
1,565,307
+30.8%
0.00%
Q1 2024$6,761,485
+35.7%
1,196,723
+3.0%
0.00%
Q4 2023$4,982,685
+29.9%
1,161,465
+5.0%
0.00%
Q3 2023$3,837,074
-24.6%
1,105,785
+1.1%
0.00%
Q2 2023$5,087,663
-62.3%
1,094,121
-62.6%
0.00%
-100.0%
Q1 2023$13,502,929
-54.9%
2,922,712
-21.1%
0.00%0.0%
Q4 2022$29,916,766
+551.1%
3,702,570
+347.2%
0.00%
Q3 2022$4,595,000
+9.7%
827,885
+3.0%
0.00%
Q2 2022$4,187,000
-80.7%
803,585
-69.6%
0.00%
-100.0%
Q1 2022$21,721,000
-8.2%
2,642,486
+66.1%
0.00%0.0%
Q4 2021$23,672,000
-26.4%
1,590,837
-6.6%
0.00%
-50.0%
Q3 2021$32,157,000
-22.6%
1,702,350
-23.8%
0.00%0.0%
Q2 2021$41,524,000
-27.4%
2,233,692
-11.2%
0.00%
-33.3%
Q1 2021$57,222,000
+482.1%
2,514,164
+455.3%
0.00%
+200.0%
Q4 2020$9,830,000
+201.9%
452,770
+39.7%
0.00%
Q3 2020$3,256,000
+102.6%
324,003
+56.4%
0.00%
Q2 2020$1,607,000
-11.8%
207,107
+16.0%
0.00%
Q1 2020$1,822,000
-2.3%
178,605
+5.4%
0.00%
Q4 2019$1,864,000
+31.5%
169,466
+8.7%
0.00%
Q3 2019$1,417,000
-16.3%
155,838
+4.8%
0.00%
Q2 2019$1,692,000
+70.1%
148,659
+70.1%
0.00%
Q1 2019$995,000
+373.8%
87,374
+275.2%
0.00%
Q4 2018$210,00023,2870.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2024
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$41,527,00015.56%
Samsara BioCapital, LLC 1,675,579$38,136,0007.03%
First Light Asset Management, LLC 2,058,447$46,850,0003.11%
FRAZIER MANAGEMENT LLC 1,001,421$22,792,0001.83%
AJU IB Investment Co., Ltd. 175,000$3,983,0001.50%
Altium Capital Management LP 226,719$5,160,0001.43%
Opaleye Management Inc. 341,950$7,783,0001.14%
Parkman Healthcare Partners LLC 202,696$4,613,0001.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$3,171,0000.84%
Eventide Asset Management 2,370,975$53,963,0000.80%
View complete list of SUTRO BIOPHARMA INC shareholders